Skip to main content

NVS Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Novartis AG News

Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact

Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.

Novartis and Roche Have Expensive Drugs That Scare Away Competitors

A brief snapshot of some medical breakthroughs that are among the costliest in the world.

5 Top Stock Gainers for Thursday Amid Central Bank Policy Calls

Stocks were mixed Thursday as investors digested policy decisions made by the U.S. Federal Reserve and the Bank of England.

Emergent BioSolutions Begins Phase 1 Trial for Universal Flu Vaccine

Emergent says its flu-vaccine candidate 'contains multiple components to induce broad, supra-seasonal immunity against influenza A viruses.'

Buyback Bonanza: Novartis May Snap Up $15 Billion of Stock

Swiss drug giant Novartis NVS said it plans to deploy up to $15 billion for share buybacks, thanks to its $21 billion sale of Roche shares.

Breaking News

Roe Decision Forces Disney, Netflix to Take a Political Stand

Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.

Netflix Lays Offs More Employees To Cut Costs

Netflix layoffs continue as the streaming giant executes a plan to cope with slow revenue growth.

These Five Things Could Help (or Hurt) Internet Stocks

Bank of America analysts outline some of the biggest issues facing Amazon, Alphabet, Meta and other internet-related stocks.

Disney Mobile Game Opens Up a New Universe

Familiar Disney characters populate an alternate reality in new interactive game.